Vantive expectations...Vantive (the proposed kidney Care spinoff from Baxter) already has $ 4.5B in revenues.
15,000 dedicated employees
Products will include peritoneal dialysis devices and solutions; connected technologies like the Sharesource remote patient management system; organ support therapies including continuous renal replacement therapy; and hemodialysis filters and systems
The business will operate in market segments totaling approximately $15 billion that collectively are estimated to grow between 3% to 4% on a compound annual basis over the next three years.
Vantive is expected to launch as an independent, publicly traded company by July 2024 or earlier, subject to satisfaction of customary conditions. ...